Clin2
NCT07107451Possibly a fitNot yet recruiting

Testing long-term protection after sesame allergy treatment

Food Allergy in Children

Part of Immune system & allergy clinical trials.

This study looks at whether children who have already completed an oral immunotherapy (desensitization) for sesame allergy can maintain protection after stopping the treatment. The goal is to see if they achieve 'sustained unresponsiveness,' meaning they can eat sesame without an allergic reaction.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
39 people
Ages
3 years to 17 years
Study type
Interventional

Who can take part

  • You must have a confirmed sesame allergy and have already completed the first part of this study, reaching a maintenance dose of 300 mg of sesame protein.
  • You need to be willing and able to cooperate with the study procedures.
  • You cannot have severe asthma or poorly controlled asthma (e.g., recent hospitalizations for asthma).
  • You cannot have other ongoing chronic conditions that require treatment, such as heart disease, epilepsy, or diabetes.
  • You cannot be taking certain medications, like daily steroids for more than a month, or have had recent steroid courses.
  • You cannot be pregnant, and you must not have had severe allergic reactions (anaphylaxis) in the last 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07158619Not yet recruiting
Sustained unresponsiveness to cashew protein after oral immunotherapy

This study checks if you can stay allergy-free to cashew nuts after completing immunotherapy. It aims to see if your immune system can handle cashew protein without reacting.

Warsaw, Masovian Voivodeship
NCT07825662Not yet recruiting
Allergy treatment vs. avoidance in babies under 2

This study compares two ways to manage food allergies in infants: giving tiny amounts of the allergen (oral immunotherapy) versus avoiding the allergen completely. It hopes to find out which approach helps young children outgrow their food allergies more effectively.

Herlev, Capital Region
NCT07592780Recruiting
Building Tolerance to Peanuts in Children and Teens

This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.

Hong Kong
NCT07764159Not yet recruiting
Mixed nut oral immunotherapy for children with multiple nut allergies

This study tests a treatment that slowly builds tolerance to multiple nut allergens (peanut and tree nuts) in children with allergies. It aims to reduce the risk of severe reactions from accidental exposure.

Poznan, Greater Poland Voivodeship
NCT07419243Recruiting· Phase 1/Phase 2
Tolerance in milk and egg allergy in children

This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.

Madrid, Madrid
NCT06976775Recruiting· Phase 2/Phase 3
Comparing two oral immunotherapy methods for milk and egg allergy

This study compares two ways of doing oral immunotherapy (gradually eating more of the allergen) for children with cow's milk or hen's egg allergy. It aims to find which method is safer and works better.

Madrid

Hear when a new Food Allergy in Children trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.